Tumor Treating Fields (TTFields) are electric fields that disrupt processes which are critical for the survival of cancer cells. This leads to immunogenic cell death and enhanced antitumor immune response. The use…
Tag: Treatment For Lung Cancer
Israeli Researchers Identify Relapse-free Treatment for Lung Cancer
The research team of Weizmann Institute have identified biomarker that helps to prevent relapse of certain types of lung cancer. This new Israeli study could open ways to more efficient treatment for…
Quratusugene Ozeplasmid for Small Cell Lung Cancer Receives Orphan Drug Designation by FDA
Genprex, Inc. is a clinical-stage gene therapy company and has announced the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to the drug, Reqorsa Immunogene Therapy (quratusugene…
ctDNA Testing To Reduce Time For Lung Cancer Treatment
According to the American Society of Clinical Oncology, around 2.4lac adults in the United States will be diagnosed with lung cancer of which 81% are NSCLC. Early diagnosis and treatment is one…
Sublober Resection for Surgical Treatment of Non-Small Cell Lung Cancer
Lung cancer is among common forms of cancers and is responsible for most deaths from cancers all over the world. One standard care for lung cancer is labectomy for surgical treatment of…
Owlstone Medical Presents Breath Biopsy Test Data for Early Lung Cancer Detection
Owlstone Medical is the global leader in Breath Biopsy for applications in early disease detection. It has presented new data for development of a screening test that help in early detection of…
Lung Cancer Drug, Osimertinib, Drastically Reduces Death Risk after Surgery
Lung cancer is among most common types of cancers in U.S. as well as around the world. According to the Centers for Disease Control and Prevention, it is responsible for nearly a…
Older Age Lung Cancer Patients
This is a fact accepted worldwide with evidences that lung cancer is old age disease. Lung cancer patients more then 50% are diagnosed after the age of 65, while 30% patients are…